Crispr Therapeutics AG F
13F holders, Q4 2024 (December 31)1holders
$39.36avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Crispr Therapeutics AG F in their 13F filings. The largest holder was VSM Wealth Advisory, LLC ($4K).
- Company
- Crispr Therapeutics AG F
- CUSIP
- 12631T108
- Latest filing quarter
- Q4 2024
Total Exit/New Position Q4 2024
No earlier quarter to compare with.
Ownership 1 holders
| VSM Wealth Advisory, LLC | 0.00% | — | 100 | $4K |
"% of holder's portfolio" is CRISPR THERAPEUTICS AG F's weight in each manager's 13F, not the share of Crispr Therapeutics AG F the manager owns.